pharmaphorum July 13, 2020
Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake of COVID-19.
The global healthcare system we knew before the COVID-19 pandemic now looks very different. This novel coronavirus has changed us, and our practices, in so many different ways, and processes throughout the healthcare network are being challenged – but it is a challenge that also provides an opportunity to reset and re-think.
For companies like Janssen, our top priority remains our patients, customers and employees. We are partnering with global and local health authorities to address immediate and long-term healthcare needs, and there is a clearer alignment of priorities than we have ever seen before. Public need, political will, scientific...
Today's Sponsors
Today's Sponsor